Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/6/e004291corr1.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850203622633111552
collection DOAJ
format Article
id doaj-art-56e30eca29d24a1e9e6c231d212cd865
institution OA Journals
issn 2051-1426
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-56e30eca29d24a1e9e6c231d212cd8652025-08-20T02:11:28ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262022-06-0110610.1136/jitc-2021-004291corr1Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinomahttps://jitc.bmj.com/content/10/6/e004291corr1.full
spellingShingle Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
Journal for ImmunoTherapy of Cancer
title Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
title_full Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
title_fullStr Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
title_full_unstemmed Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
title_short Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
title_sort correction multicenter single arm phase ii trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
url https://jitc.bmj.com/content/10/6/e004291corr1.full